During infectious disease emergencies, it may be necessary to deploy new therapies without conclusive evidence for their effectiveness. During the SARS-CoV-2 pandemic, several countries used registries to track the use of COVID-19 convalescent plasma (CCP). Those registries provided evidence that CCP was effective when used early and with high titer.
Download full-text PDF |
Source |
|---|---|
| http://www.ncbi.nlm.nih.gov/pmc/articles/PMC10746279 | PMC |
| http://dx.doi.org/10.1128/mbio.02565-23 | DOI Listing |
Publication Analysis
Top Keywords
infectious disease
8
observational registry
4
registry studies
4
studies infectious
4
disease emergency
4
emergency infectious
4
disease emergencies
4
emergencies deploy
4
deploy therapies
4
therapies conclusive
4
Similar Publications
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!